Last reviewed · How we verify
NCT04339322: COVID-19
Characteristics and Outcome of Coronavirus Disease 2019 (COVID-19) in Egypt
trial testing Follow up in Characteristics Diseases in 200 participants. Status unknown.
30 July 2020
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 1 May 2020 |
| Primary completion | 30 July 2020 |
| Estimated completion | 30 July 2020 |
Drugs / interventions tested
- Follow up
Conditions studied
- Characteristics Diseases — all drugs for Characteristics Diseases →
- Outcome, Fatal — all drugs for Outcome, Fatal →
Sponsor
Assiut University
Who can join
Eligibility, any sex, with Characteristics Diseases or Outcome, Fatal. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The World Health Organization (WHO) has recently declared coronavirus disease 2019 (Covid-19) a public health emergency of international concern. Egypt is one of the countries that has been infected by Covid-19. The characteristics of clinical presentation, laboratory and radiological data are not yet studied. Outcomes of covid-19 in Egypt also have not been described yet.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04339322
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Follow up
Trials testing the same drug.
- NCT06779344 — MxA and CRP-Guided Use of Antimicrobial Agents for AECOPD · NA · not yet recruiting
- NCT06137352 — Two Domestic HPV Vaccines and Imported HPV Vaccines in Women Aged 13-14 Years Study on Immunogenicity · not yet recruiting
- NCT05745597 — Prognostic Study of HPV Virus Integration in Women With HSIL · unknown
- NCT05282095 — Effect of HPV Integration on Prognosis of Young Women With CIN2 in China · recruiting
- NCT05123417 — Knowledge and Practices of Preventing Pressure Ulcers · NA · completed
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04339322 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 9 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04339322.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing